Practical screening and monitoring tools for out-of-specification risk in biological products under finite sample sizes
{{output}}
Evaluating the risk of out-of-specification (OOS) occurrence before it happens is essential to prevent delays or interruptions in the supply of biological products. This study proposes a practical and quantitative evaluation approach using two indices, S1 and ... ...
